Patients with hematologic malignancy, however, were in a high thrombomodulin quartile (P = 0.036), and patients with shock at admission were in a higher tPA and PAI-1 quartile (both P <0.01, data not shown). The gene discussed is THBD; the disease is hematologic disorder.